• Maximilian Leiblein, Tobias Kolb, Lion Christian, Katrin Schröder, Ceyhan Yaman, Alexander Schaible, Ingo Marzi, Dirk Henrich, and Maren Janko.
• Department of Trauma, Hand and Reconstructive Surgery, University Hospital, Goethe University Frankfurt am Main, 60590 Frankfurt, Germany.
• Materials (Basel). 2020 Jun 9; 13 (11).

AbstractThe Masquelet technique for the treatment of large bone defects is a two-stage procedure based on an induced membrane. We eliminate the first surgical step by using a decellularized dermal skin graft (Epiflex®) populated with bone marrow mononuclear cells (BMC), as a replacement for the induced membrane. The aim of this study was to demonstrate the feasibility of this technology and provide evidence of equivalent bone healing in comparison to the induced membrane-technique. Therefore, 112 male Sprague-Dawley rats were allocated in six groups and received a 10 mm femoral defect. Defects were treated with either the induced membrane or decellularized dermis, with or without the addition of BMC. Defects were then filled with a scaffold (β-TCP), with or without BMC. After a healing time of eight weeks, femurs were taken for histological, radiological and biomechanical analysis. Defects treated with Epiflex® showed increased mineralization and bone formation predominantly in the transplanted dermis surrounding the defect. No significant decrease of biomechanical properties was found. Vascularization of the defect could be enhanced by addition of BMC. Considering the dramatic reduction of a patient's burden by the reduced surgical stress and shortened time of treatment, this technique could have a great impact on clinical practice.

3 keywords...

hide…